Story perspectives

Anti-Seizure Drug Shows Promise Against Alzheimer’s Development

3/4/2026

Summary

Story summary

Northwestern University researchers report that levetiracetam, an anti-seizure medication, may help prevent Alzheimer's disease by blocking the formation of toxic amyloid beta peptides.
The findings, based on animal models, suggest the drug could delay cognitive decline but have not yet been tested in humans.
Researchers caution that levetiracetam is not a cure and must be taken early, up to 20 years before symptoms appear.
Side effects include drowsiness and mood changes.
The team plans to develop a more effective version of the drug, with funding from the National Institutes of Health and the Cure Alzheimer's Fund.

1 of 1

Story summary

Northwestern University researchers report that levetiracetam, an anti-seizure medication, may help prevent Alzheimer's disease by blocking the formation of toxic amyloid beta peptides.
The findings, based on animal models, suggest the drug could delay cognitive decline but have not yet been tested in humans.
Researchers caution that levetiracetam is not a cure and must be taken early, up to 20 years before symptoms appear.
Side effects include drowsiness and mood changes.
The team plans to develop a more effective version of the drug, with funding from the National Institutes of Health and the Cure Alzheimer's Fund.